Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,017
archived clinical trials in
Angina

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Hahnemann Hospital
mi
from
Philadelphia, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Hahnemann Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Holy Spirit Hospital
mi
from
Wormleysburg, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Holy Spirit Hospital
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Main Line Health Heart Center/The Lankenau Hospital
mi
from
Wynnewood, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Main Line Health Heart Center/The Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
York Hospital
mi
from
York, PA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Miriam Hospital
mi
from
Providence, RI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
AnMed Health
mi
from
Anderson, SC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Providence Hospital-SC
mi
from
Columbia, SC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Providence Hospital-SC
mi
from
Columbia, SC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sanford USD Medical Center
mi
from
Sioux Falls, SD
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Memorial Health System
mi
from
Chattanooga, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Memorial Health System
mi
from
Chattanooga, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
West Clinic d/b/a Memphis Heart Clinic
mi
from
Memphis, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
West Clinic d/b/a Memphis Heart Clinic
mi
from
Memphis, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Thomas Hospital
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Thomas Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Vanderbilt Vniversity Medical Center
mi
from
Nashville, TN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Vanderbilt Vniversity Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Amarillo Heart Clinical Research Institute Inc.
mi
from
Amarillo, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Amarillo Heart Clinical Research Institute Inc.
mi
from
Amarillo, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Capital Cadiovascular Specialists
mi
from
Austin, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Capital Cadiovascular Specialists
mi
from
Austin, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Methodist Hospital
mi
from
Houston, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lubbock Heart Hospital
mi
from
Lubbock, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lubbock Heart Hospital
mi
from
Lubbock, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Permian Research Foundation
mi
from
Odessa, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Permian Research Foundation
mi
from
Odessa, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
South Texas Methodist Hospital
mi
from
San Antonio, TX
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
South Texas Methodist Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Virginia Cardiovascular Consultants
mi
from
Fredericksburg, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Virginia Cardiovascular Consultants
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Carilion Roanoke Memorial
mi
from
Roanoke, VA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Carilion Roanoke Memorial
mi
from
Roanoke, VA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Overlake Hospital Medical Center
mi
from
Bellevue, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Overlake Hospital Medical Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Providence Everett Medical Center
mi
from
Everett, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Providence Everett Medical Center
mi
from
Everett, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Tacoma
mi
from
Tacoma, WA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Tacoma
mi
from
Tacoma, WA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St Mary's Medical Hospital
mi
from
Huntington, WV
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St Mary's Medical Hospital
mi
from
Huntington, WV
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Patient-Reported Preferences Affecting Revascularization Decisions
Patient-Reported Preferences Affecting Revascularization Decisions
Status: Enrolling
Updated:  8/2/2016
Duke University Hospital
mi
from
Durham, NC
Patient-Reported Preferences Affecting Revascularization Decisions
Patient-Reported Preferences Affecting Revascularization Decisions
Status: Enrolling
Updated: 8/2/2016
Duke University Hospital
mi
from
Durham, NC
Click here to add this to my saved trials
Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study
Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study
Status: Enrolling
Updated:  12/19/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study
Home Hypnotherapy for Refractory Functional Chest Pain: A Pilot Study
Status: Enrolling
Updated: 12/19/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated:  2/28/2017
Hospital for Special Surgery
mi
from
New York, NY
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated:  2/28/2017
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
The Post-Operative Statin for Thromboprophylaxis & Cardiovascular Outcomes Protection (POST-OP) Pilot Trial
Status: Enrolling
Updated: 2/28/2017
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Lidocaine 5% Patch (Lidoderm) for the Perioperative Prevention of Acute and Chronic Chest Pain Following Robotic Valve Surgery
Lidocaine 5% Patch (Lidoderm) for the Perioperative Prevention of Acute and Chronic Chest Pain Following Robotic Valve Surgery
Status: Enrolling
Updated:  4/17/2017
Cleveland Clinic
mi
from
Cleveland, OH
Lidocaine 5% Patch (Lidoderm) for the Perioperative Prevention of Acute and Chronic Chest Pain Following Robotic Valve Surgery
Lidocaine 5% Patch (Lidoderm) for the Perioperative Prevention of Acute and Chronic Chest Pain Following Robotic Valve Surgery
Status: Enrolling
Updated: 4/17/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Scottsdale Healthcare
mi
from
Scottsdale, AZ
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
University of California, Irvine Medical Center
mi
from
Orange, CA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
University of Florida Gainesville
mi
from
Gainesville, FL
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
University of Florida Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Pepin Heart Hospital
mi
from
Tampa, FL
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Pepin Heart Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Piedmont Hospital
mi
from
Atlanta, GA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Washington Adventist Hospital
mi
from
Takoma Park, MD
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Washington Adventist Hospital
mi
from
Takoma Park, MD
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Massachusetts General Hospital
mi
from
Boston, MA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated:  6/8/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
An Observational Study of Cholesterol in Coronary Arteries
Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry
Status: Enrolling
Updated: 6/8/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials